YS BIOPHARMA CO LTD (YS) Stock Price, Quote, News and Overview
NASDAQ:YS - Nasdaq - KYG9845F1090 - Common Stock - Currency: USD
YS Quote, Performance and Key Statistics
1.02
+0.11 (+12.45%)
The current stock price of YS is 1.02 USD. In the past month the price increased by 27.5%. In the past year, price decreased by -22.73%.
YS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About YS
Company Profile
YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company is headquartered in Beijing, Beijing and currently employs 773 full-time employees. The company went IPO on 2021-07-30. The firm's vaccine product YSJATM rabies vaccine has been commercialized. The firm also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Company Info
YS BIOPHARMA CO LTD
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park
Beijing BEIJING CN
Employees: 773
Company Website: https://www.ysbiopharm.com/
Phone: 17327133678
YS BIOPHARMA CO LTD / YS FAQ
What is the stock price of YS BIOPHARMA CO LTD today?
The current stock price of YS is 1.02 USD. The price increased by 12.45% in the last trading session.
What is the ticker symbol for YS BIOPHARMA CO LTD stock?
The exchange symbol of YS BIOPHARMA CO LTD is YS and it is listed on the Nasdaq exchange.
On which exchange is YS stock listed?
YS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for YS BIOPHARMA CO LTD stock?
9 analysts have analysed YS and the average price target is 4.26 USD. This implies a price increase of 317.5% is expected in the next year compared to the current price of 1.02. Check the YS BIOPHARMA CO LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is YS BIOPHARMA CO LTD worth?
YS BIOPHARMA CO LTD (YS) has a market capitalization of 192.10M USD. This makes YS a Micro Cap stock.
How many employees does YS BIOPHARMA CO LTD have?
YS BIOPHARMA CO LTD (YS) currently has 773 employees.
What are the support and resistance levels for YS BIOPHARMA CO LTD (YS) stock?
YS BIOPHARMA CO LTD (YS) has a support level at 0.9 and a resistance level at 1.02. Check the full technical report for a detailed analysis of YS support and resistance levels.
Is YS BIOPHARMA CO LTD (YS) expected to grow?
The Revenue of YS BIOPHARMA CO LTD (YS) is expected to decline by -6.61% in the next year. Check the estimates tab for more information on the YS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy YS BIOPHARMA CO LTD (YS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of YS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of YS, evaluating the profitability, health, valuation and growth aspects
- YS BIOPHARMA CO LTD (YS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- YS BIOPHARMA CO LTD (YS) Sales and EPS estimates to see what analysts future expectations are.
- YS BIOPHARMA CO LTD (YS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- YS BIOPHARMA CO LTD (YS) Insider and Institutional Ownership to learn about the owners and their transactions.
- YS BIOPHARMA CO LTD (YS) Stock Chart to make your own analysis
- YS BIOPHARMA CO LTD (YS) Latest news and press-releases to stay up to date.
Does YS BIOPHARMA CO LTD (YS) stock pay dividends?
YS does not pay a dividend.
What is the Price/Earnings (PE) ratio of YS BIOPHARMA CO LTD (YS)?
YS BIOPHARMA CO LTD (YS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.42).
YS Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to YS. When comparing the yearly performance of all stocks, YS is one of the better performing stocks in the market, outperforming 96.68% of all stocks.
YS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to YS. Both the profitability and financial health of YS have multiple concerns.
YS Financial Highlights
Over the last trailing twelve months YS reported a non-GAAP Earnings per Share(EPS) of -0.42. The EPS decreased by -9348.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.59% | ||
| ROE | -50.88% | ||
| Debt/Equity | 0.65 |
YS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to YS. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 19.72% and a revenue growth -6.61% for YS